CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
4.040
+0.120 (3.06%)
Mar 25, 2026, 4:00 PM EDT - Market closed
CervoMed Market Cap
CervoMed has a market cap or net worth of $37.41 million as of March 26, 2026. Its market cap has increased by 92.03% in one year.
Market Cap
37.41M
Enterprise Value
16.54M
1-Year Change
92.03%
Ranking
Category
Stock Price
$4.04
Market Cap Chart
Since August 17, 2023, CervoMed's market cap has decreased from $43.26M to $37.41M, a decrease of -13.54%. That is a compound annual growth rate of -5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 37.41M | -48.83% |
| Dec 31, 2025 | 73.10M | 278.47% |
| Dec 31, 2024 | 19.31M | -55.39% |
| Dec 29, 2023 | 43.30M | 0.08% |
| Aug 17, 2023 | 43.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 39.97M |
| Atara Biotherapeutics | 39.62M |
| Estrella Immunopharma | 38.52M |
| Apollomics | 38.22M |
| NextCure | 37.06M |
| LeonaBio | 36.95M |
| Veru Inc. | 36.92M |
| NovaBay Pharmaceuticals | 36.74M |